Health

WHO Goodwill Ambassador for Leprosy Elimination Has Audience with Pope Francis

Pope Supports Continued Efforts Against Leprosy, Reflects on Tragedy of War TOKYO, Jan. 27, 2023 /PRNewswire/ -- WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa had an audience with His Holiness Pope Francis at the Vatican onJanuary 26, 2023, during which he requested the Pope's su...

2023-01-27 22:00 3739

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

* SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in theKingdom of Saudi Arabia(KSA) * SK bioscience also explained a new global partnership model aiming to promote public health in deve...

2023-01-27 20:00 3953

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

* Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit ofKRW 312.8 billion. * FY'22 consolidated revenue of KRW 3.00 trillion and FY'22 operating profit ofKRW 983.6 billion. * Strong growth momentum expected to continue with active expansions in capacity, geography, an...

2023-01-27 14:52 3529

Akeso Received First Tranche of US$300 Million Upfront Payment from Summit! Summit Is Accelerating Clinical Development of Ivonescimab

HONG KONG, Jan. 26, 2023 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company"), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced the Hart-Scott-Rodino (HSR) Act filing has c...

2023-01-26 20:24 3590

Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

* Longevity Biomedical is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase health span for the rapidly growing global aging pop...

2023-01-26 19:30 2980

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

* First Generic of Abraxane in Korea, World 4th Commercial Scale-Up * Global tech-transfer expected to US, Japan, and Europe SEONGNAM, South Korea ,Jan. 26, 2023 /PRNewswire/ -- SN BioScience (CEO Park Young-hwan) and Boryeong (CEOJang Doo-hyun) signed a domestic manufacturing technology transf...

2023-01-26 14:31 1964

ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies

NANJING, China, Jan. 25, 2023 /PRNewswire/ -- As the tissue engineering and regenerative medicine industry has shown tremendous potential in clinical practices in recent years worldwide,China's blue ocean market welcomes the first wave of acquisitions. ReLive Biotechnologies, Ltd. ("ReLive" or "...

2023-01-26 12:11 2000

iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax

* Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack * Provides the most potent bactericidal ability that no other PEP antibiotics in the market can exhibit * Further developments are planned to conduct with a licensing/col...

2023-01-26 10:34 1889

HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders

CAMBRIDGE, Mass., Jan. 26, 2023 /PRNewswire/ -- HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated byHarbour BioMed (HKEX: 02142), announced that it completed seed financing to advance its leading programs, novel antibody therapies to treat congenital adrenal hype...

2023-01-26 09:22 2878

ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies

NANJING, China, Jan. 25, 2023 /PRNewswire/ -- As the tissue engineering and regenerative treatment industry has shown tremendous potential in clinical practices in recent years worldwide,China's blue ocean market welcomes the first wave of acquisitions. ReLive Biotechnologies, Ltd. ("ReLive" or ...

2023-01-26 08:11 2208

Singleron launches single cell eQTL analysis as part of their sequencing service

A new bioinformatic pipeline to investigate single cell eQTL analysis is now offered in the sequencing service from Singleron Biotechnologies. COLOGNE, Germany, Jan. 25, 2023 /PRNewswire/ -- Bioinformatic experts at Singleron Biotechnologies , a leader in single cell sequ...

2023-01-25 19:00 1945

Amcor to report Half Year 2023 results

ZURICH, Jan. 24, 2023 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its Half Year 2023 results for the six months ended31 December 2022 after the US market closes on Tuesday7 February 2023.   A conference call and webcast to discuss the results will be held at 5.30pm US Eastern ...

2023-01-25 06:10 3766

Complete Genomics to Announce New Product Launches at AGBT General Meeting

SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc. , a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"), today announced it plans to launch three new products at the Advances in Genome Biology and Techn...

2023-01-24 20:30 2256

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

NEW YORK, Jan. 20, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ: UPTD) today announced that, in order to extend the date by which the Company mush complete its initial business combination fromJanuary 19, 2023 to February 19, 2023, for each public share that...

2023-01-21 05:33 6369

CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI

SHANGHAI, Jan. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thata poster presentation highlighting the Phase 1 preliminary result...

2023-01-20 21:50 4522

China Jo-Jo Drugstores Announces $2.625 Million Registered Direct Offering

HANGZHOU, China, Jan. 20, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it h...

2023-01-20 21:30 6148

International Symposium at the Vatican on Hansen's Disease To Focus on Theme of "Leave No One Behind"

TOKYO, Jan. 20, 2023 /PRNewswire/ -- French Raoul Follereau Fondation, Italian Association Amici di Raoul Follereau and Sasakawa Leprosy (Hansen's Disease) Initiative, in collaboration with the Dicastery for Promoting Integral Human Development, will co-host the "International Symposium at the Va...

2023-01-20 21:00 3931

Revitalize Beauty Through Science: Skincare Tech Brand AMIRO Unveils Its All-In-One LED Light Therapy Face Mask

SHENZHEN, China, Jan. 20, 2023 /PRNewswire/ -- Tech-centric beauty brand AMIRO has just unveiled its latest skincare device, the AMIRO L1 LED Light Therapy Face Mask, as a response to consumer demand. AMIRO L1 LED Light Therapy Face Mask The ...

2023-01-20 20:56 3254

SK bioscience Appoints New Executives to Accelerate New Growth Strategies

* Two biopharmaceutical experts join SK bioscience to strengthen the future strategies * With recruitment of global talent and capabilities accumulated during the COVID-19 pandemic, SK bioscience will continue to achieve sustainable growth SEOUL, South Korea, Jan. 20, 2023 /PRNewswire/ -- SK ...

2023-01-20 20:00 2748

DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression

PRINCETON, N.J., SHANGHAI and SUZHOU, China, Jan. 20, 2023 /PRNewswire/ -- Duality Biologics ("DualityBio"), a clinical-stage biotech company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers and autoimmune diseases, announced that the U.S. Food...

2023-01-20 18:00 3275
1 ... 105106107108109110111 ... 273